With COVID-19, people with diabetes face the added risk of poorer outcomes if infected, creating an even greater urgency to ensure proper management of overall health and chronic conditions.
As a nation we've reached a tipping point as to what patients can bear when it comes to the price of insulin, a drug used to control blood sugar levels for people with insulin-dependent diabetes. Millions of people who need this life-saving medication face affordability barriers in the form of rising insulin prices and out-of-pocket costs.
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
